FIELD: medicine. SUBSTANCE: method involves pouring biological fluid under study into the cells of two flat bottom 96-celled palettes. One cell is filled with physiological salt solution instead of the biological fluid and substrate mixture for peroxidase is added into the other cells of the first palette in use. Chromogen solution containing no hydrogen peroxide is added into the cells of the second palette and then, 50 mcl of 10% sulfuric acid is added 5-10 min later. Color intensity is measured in palette photometer at 492 nm wavelength. EFFECT: enhanced accuracy in determining functional activity of extracellular peroxidases with free radical influence being taken into account. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
TEST SET FOR DIAGNOSING NEUROLOGIC DISEASES | 1995 |
|
RU2112243C1 |
METHOD OF TREATING CHRONIC PURULENT RHINOSINUSITES | 2000 |
|
RU2161983C1 |
IMMUNE-ENZYME TEST SYSTEM FOR DETERMINING SPECIFIC ANTIBODIES TO MORAXELLA BOVOCULI BACTERIA IN BOVINE BLOOD SERUM | 2018 |
|
RU2687747C1 |
METHOD TO TREAT CHRONIC PURULENT RHINOSINUSITIS | 2001 |
|
RU2178676C1 |
SET FOR QUANTITATIVE DETERMINATION OF AVERMECTINS VIA SINGLE-STEP COMPETITIVE ENZYME-IMMUNOASSAY | 2009 |
|
RU2416094C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF BACTERIAL CONJUNCTIVITIS | 2011 |
|
RU2446399C1 |
METHOD OF TREATMENT OF CHRONIC PURULENT RHINOSINUSITIS | 2007 |
|
RU2345784C1 |
METHOD FOR IDENTIFYING BIOLOGICAL MARKERS DETECTED IN HUMAN BIOLOGICAL MATERIALS IN VIEW OF POSSIBLE PRESENCE OF PATHOLOGICAL CONDITIONS OF THE HUMAN BODY, INCLUDING ONCOLOGICAL DISEASES, IMPLEMENTED BY MEANS OF MULTIPLEX IMMUNOENZYME SANDWICH IMMUNOASSAY | 2021 |
|
RU2779104C1 |
COMPLEX ANTIGEN OF MEASLES VIRUS USED AS A COMPONENT OF IMMUNOENZYMOMETRIC TEST SYSTEM FOR DIAGNOSTICS OF ANTIBODIES TO MEASLES VIRUS | 2010 |
|
RU2441666C1 |
Method for producing Chinese hamster ovary cell strain, being a producer of recombinant SARS-CoV-2 virus protein RBD, Chinese hamster ovary cell strain, producer of recombinant SARS-CoV-2 protein RBD, method for producing recombinant SARS-CoV-2 virus protein RBD, test system for enzyme immunoassay of human serum or plasma, and use thereof | 2020 |
|
RU2723008C1 |
Authors
Dates
2002-02-27—Published
2000-10-13—Filed